

Sterile Injection Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global sterile injection market is projected to grow significantly, driven by increasing demand for safe and efficient drug delivery methods. The market size is estimated to reach USD 657.4 million by 2027, with North America dominating the market due to stringent regulatory frameworks and technological advancements. Request Sample Report
◍ Johnson & Johnson Merck & Co.
◍ GlaxoSmithKline
◍ Gilead Sciences
◍ Baxter International
◍ Amgen
◍ Novartis AG
◍ Sanofi
◍ Pfizer
◍ Novo Nordisk A/S
◍ Merck & Co., Inc.
The Sterile Injection Market is highly competitive with key players such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, Gilead Sciences, Baxter International, Amgen, Novartis AG, Sanofi, Pfizer, Novo Nordisk A/S, and Merck & Co., Inc. These companies utilize sterile injections for various medical therapies and drug delivery systems, contributing to the market's growth.
- Johnson & Johnson: Sales revenue of $82.1 billion
- Merck & Co.: Sales revenue of $46.8 billion - GlaxoSmithKline: Sales revenue of $42.2 billion.
Request Sample Report
Tumor
Cardiovascular Diseases
Infectious Disease
Diabetes
Other
◍ Monoclonal Antibodies
Insulin
Immunoglobulin
Cytokines
Blood Factors
Other
Request Sample Report
$ 73.75 Billion
Request Sample Report